Correlation Between AbbVie and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AbbVie and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Milestone Pharmaceuticals, you can compare the effects of market volatilities on AbbVie and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Milestone Pharmaceuticals.
Diversification Opportunities for AbbVie and Milestone Pharmaceuticals
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AbbVie and Milestone is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of AbbVie i.e., AbbVie and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between AbbVie and Milestone Pharmaceuticals
Given the investment horizon of 90 days AbbVie Inc is expected to generate 0.31 times more return on investment than Milestone Pharmaceuticals. However, AbbVie Inc is 3.2 times less risky than Milestone Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 15,180 in AbbVie Inc on August 27, 2024 and sell it today you would earn a total of 2,515 from holding AbbVie Inc or generate 16.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AbbVie Inc vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| AbbVie Inc |
| Milestone Pharmaceuticals |
AbbVie and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AbbVie and Milestone Pharmaceuticals
The main advantage of trading using opposite AbbVie and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| AbbVie vs. Eliem Therapeutics | AbbVie vs. HCW Biologics | AbbVie vs. Scpharmaceuticals | AbbVie vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |